The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.

Hands holding a glass lung to evoke image of lung cancer

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing treatment response in melanoma and NSCLC patients receiving immune checkpoint inhibitors.

The results indicate that iRECIST is better suited for capturing atypical treatment responses to immunotherapies, especially in patients experiencing pseudoprogression. iRECIST could thus contribute to a more accurate evaluation of treatment response and improved immunotherapy outcomes.

Read more about the study here.

Related Resources

Related Resources

Doctor using the Template Designer on her laptop

The Template Designer in Use: Interview with Dr. Madelaine Hettler

Structured, well-organized data are the foundation of meaningful research. But how can they be captured effectively in practice? Dr. Madelaine…

Doctor using the Template Designer

Research Insights: The Template Designer in Use

Structured and well-organized data are essential building blocks for successful research and clinical projects. The Template Designer provides a tool…

Computer screen showing oncologic imaging: lung cancer screening in mint Lesion

Lung Cancer Screening in Germany – A Turning Point for Early Detection

Few topics are currently as impactful in radiology as lung cancer screening. From 2026, Germany is expected to roll out a nationwide program, marking…